Complete secondary botulinum toxin therapy failure in blepharospasm [5]

Journal of Neurology

Volumn 247, Issue 10, 2000, Pages 809-810

  Dressler, Dirk ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTHRALGIA; BLEPHAROSPASM; CASE REPORT; DYSESTHESIA; EYELID EDEMA; FEMALE; HUMAN; IMMUNOREACTIVITY; INJECTION; LETTER; LEUKOCYTE COUNT; NAUSEA; PRIORITY JOURNAL; TACHYCARDIA; TREATMENT FAILURE;

ANTI-DYSKINESIA AGENTS; ANTIBODY FORMATION; BLEPHAROSPASM; BOTULINUM TOXINS; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0033735851     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150070100     Document Type: Letter

References (7)

1. Long-term treatment of cervical dystonia with botulinum toxin A: Efficacy, safety, and antibody frequency. German Dystonia Study Group
2. Absence of antibody production in patients treated with botulinum A toxin
3. Negative antibody response to long-term treatment of facial spasm with botulinum toxin
4. Botulinum toxin therapy failure: Causes, evaluation procedures and management strategies
5. Clinical features of antibody induced complete secondary botulinum toxin therapy failure
6. Response and immunoresistance to botulinum toxin injections
7. Risk factors for therapy failure